A who's who of integrity agreements

Share this article:

FDA anger can bring down a corporate integrity agreement on a drug or device maker. Health and Human Services' Office of the Inspector General has a lineup of the pharma companies who are on notice. Of the 20 listed, only one has an end date or has been closed (congratulations, Medtronic).

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.